IMPACT OF FINANCES ON DIABETES CARE AND SUPPLY ACCESS DURING COVID-19 AMONG U.S. ADULTS LIVING WITH DIABETES

ABSTRACT

Background and Aims: Diabetes is one of the most financially burdensome diseases in the U.S., and the COVID-19 pandemic has exacerbated financial stress among people with diabetes (PWD). This study investigated how finances have impacted diabetes care from June 2020 to June 2021. Methods: In June 2021, 4,780 adults living with diabetes in the U.S. completed an online survey in which they reported the influence of finances on their diabetes care on a scale of 1 to 5 and whether they delayed medical care due to cost in the last year. Respondents who reported delaying their medical care due to cost (n = 759) were asked in which ways they delayed care. Results: Finances have a significant influence on diabetes care for 24% of respondents. In the last year, 13% of PWD delayed care due to cost, and those in lower income brackets were more likely to delay care. Among those who delayed care, 48% of CGM users delayed ordering CGM supplies and 30% of CGM users delayed starting on a new diabetes device. Half of respondents using a pump delayed ordering pump supplies. Among those on MDI, 50% delayed an insulin refill compared to 38% of respondents using a pump. Conclusions: At a time when high costs of care are intersecting with pandemic-related financial stress, PWD are postponing care and delaying orders of necessary supplies, which may lead to further health complications. COVID-19 has amplified the need for policy and industry to take action to ensure PWD can access the care and supplies they need to live.